No black box warning on record for Ganciclovir

As of the latest FDA labeling reviewed, Ganciclovir (GANCICLOVIR SODIUM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ganciclovir medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Renal Impairment: Increased serum creatinine levels have been observed with the use of Ganciclovir Injection, particularly in elderly patients and transplant recipients receiving concomitant nephrotoxic drugs. Monitor renal function during therapy with Ganciclovir Injection, particularly in elderly patients and in patients taking other nephrotoxic drugs, and reduce dosag

No black box warning on record for Ganciclovir

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Renal Impairment: Increased serum creatinine levels have been observed with the use of Ganciclovir Injection, particularly in elderly patients and transplant recipients receiving concomitant nephrotoxic drugs. Monitor renal function during therapy with Ganciclovir Injection, particularly in elderly patients and in patients taking other nephrotoxic drugs, and reduce dosag

Ganciclovir Black Box Warning

No black box warning on record for Ganciclovir

Other warnings & precautions

Ganciclovir Black Box Warning

No black box warning on record for Ganciclovir

Other warnings & precautions